Research labs within Université Paris Cité
List
Functional and Adaptive Biology
BFA – UMRS 8251
Today, it is common to use computational methods to discover new drugs. However, in recent years, new challenges have emerged. It is now necessary to take into account the multiple interactions between a drug and its targets, as well as to seek alternatives to traditional drugs. The team focuses on two main axes: Profiling, which thoroughly studies therapeutic proteins and predicts how molecules interact with them, and Peptides, which develop new peptides to target protein interactions. They also have a platform called RPBS that aids in these research endeavors.
Clinical Investigation Center in Vaccinology
CIC – Cochin-Pasteur
Institut Pasteur
The Vaccine Trials Center of Cochin Hospital and the Institut Pasteur have established the Cochin-Pasteur Clinical Investigation Center in Vaccinology, in collaboration with Inserm. This specialised center evaluates new vaccines, addressing a global public health need. It conducts clinical trials on new vaccines, with financial support from Inserm and DHOS. The first clinical trial evaluates a vaccine against Shigella dysenteriae, launched in June 2005.
Environmental Toxicity Therapeutic Targets Cellular Signaling & Biomarkers
Team 7: Cell death and Host Pathogen Interaction
T3S – UMRS 1124
Infectious diseases are one of the leading causes of death worldwide, especially in developing countries. The team focuses on understanding cell death during host-pathogen interactions. It investigates how cells die and how microbes persist even after treatment. The goal is to find new drugs to enhance existing therapies against HIV and other infections. The team also aims to understand how parasites like Leishmania affect cells and how this influences the immune response. Lastly, it explores how viral infections trigger the release of certain molecules in the body, which may prolong the illness.
Infection, Antimicrobials, Modeling, Evolution
IAME – UMR 1137
Laboratoire Européen Associé
LEA – INSERM “Emerging Antibiotic Resistance in Gram-negative Bacteria”
EMergATB-Resist – IAME – UMR 1137
The EMergATB-Resist research project, led by Patrice NORDMANN at the University of Fribourg and in collaboration with Erick DENAMUR at IAME, aims to rapidly detect antibiotic resistance in multi-drug resistant (MDR) Gram-negative bacteria, understand the genetic mechanisms of resistance, develop rapid diagnostic tests, and create new treatments against carbapenemase-producing bacteria.
Institut de recherche Saint-Louis
Genomes and Cell Biology of Diseases team
Inserm U944 – CNRS UMR 7212
Emerging Virus Biology team
UMRS 944
The team investigates how viruses affect human cells and how this influences our susceptibility to viral diseases. It focuses on RNA viruses, such as those transmitted by mosquitoes or respiratory viruses, which can cause severe illnesses. The goal is to understand how these viruses manipulate cells to spread and evade our immune system. This research could aid in developing new antiviral treatments. The team employs various advanced techniques such as proteomics and genomic analysis to explore these mechanisms.
Human Immunology, Pathophysiology, Immunotherapy team
HIPI – U976
Established in 2019, affiliated with Inserm and Université Paris Cité. Under the direction of Jean-Christophe BORIES, the unit comprises over 200 members working on immuno-oncology, stem cells and immunity, as well as immuno-inflammation. In addition to these areas, HIPI explores cross-cutting projects to develop combination therapies. Its goal is to identify new immunological mechanisms to better understand and treat immune diseases. In collaboration with hospital clinical services, HIPI also promotes innovation and the training of young researchers and physicians, while advocating for scientific integrity.
À lire aussi
Welcome Party – October 9th, 2024
On October 9th the first ever start-of-the-year Welcome Party of the "One Health - Emerging Infectious Diseases" Graduate School took place on the Barge du CROUS.The party was a wonderfully festive occasion to warmly welcome our 2024 Master's students and PhD fellows,...
Acceleration Strategies against Emerging Infectious Diseases
On September 30 2024, the 1H-EID team attended the national get together in Montpellier, organized by the Agence d'Innovation en Santé and the ANRS, celebrating 3 years of the governmental "stratégie d'accélération" against emerging infectious diseases, within the...
Looking Back at the EAIE Fair in Toulouse
“One Health” conference – Saint-Brieuc
The conference “The One Health Challenges to tackle Infectious Diseases” took place from June 12th to 14th, in Saint-Brieuc, France. 1H-EID was among the official sponsors of the event and was present on site with an information stand, shared with the Graduate School...